Conduction block of varicella zoster virus neuropathy.
Murakami
T
T
Division of Neurology, Department of Internal Medicine, Kawasaki Medical School, Kurashiki City, Okayama, Japan. tatsum@med.kawasaki-m.ac.jp
Shibazaki
K
K
Kurokawa
K
K
Ichikawa
Y
Y
Ohsawa
Y
Y
Sunada
Y
Y
D000200:Action Potentials; D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D004568:Electrodiagnosis; D004576:Electromyography; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006562:Herpes Zoster / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications; D008279:Magnetic Resonance Imaging; D008475:Median Nerve / Q000503:physiopathology; D008875:Middle Aged; D009431:Neural Conduction; D010523:Peripheral Nervous System Diseases / Q000150:complications* / Q000175:diagnosis* / Q000503:physiopathology; D011239:Prednisolone / Q000627:therapeutic use; D011826:Radial Nerve / Q000503:physiopathology
D000998:Antiviral Agents; D005938:Glucocorticoids; D011239:Prednisolone; D000212:Acyclovir